Anthem Biosciences Ltd. IPO

Anthem Biosciences IPO is a Rs 3,395 crore book-built issue, consisting entirely of an offer for sale of 5.96 crore shares. The IPO opens for subscription on July 14, 2025, and closes on July 16, 2025. Allotment is expected on July 17, with listing on BSE and NSE scheduled for July 21. The price band is set at Rs 540 to Rs 570 per share. Retail investors can apply for a minimum of 26 shares, requiring an investment of Rs 14,040. For sNII, the minimum application is 14 lots (364 shares) amounting to Rs 2,07,480, while bNII is 68 lots (1,768 shares). JM Financial is the lead manager and Kfin Technologies is the registrar.

RHP
View
DRHP
View
Open Date

2025-07-14

Close Date

2025-07-16

Anthem Biosciences Ltd. IPO Details

Check out the issue details for Anthem Biosciences Ltd. IPO as disclosed in SEBI.

Price Band

₹ 540 - 570

Issue Size

3395 Cr.

Issue Type

Book Built

Open

2025-07-14

Close

2025-07-16

Listing Date

2025-07-21

Company Financials

You can get the following financial statements of Anthem Biosciences Ltd. as of now.

Anthem Biosciences IPO Details

The details about the Anthem Biosciences IPO are as follows:

  • The issue size of the IPO is Rs 3,395.00 Cr.
  • The price band for Anthem Biosciences IPO is Rs 540 to Rs 570.
  • The shares of Anthem Biosciences IPO will list on BSE and NSE on 21 July 2025.
  • The latest tentative GMP of Anthem Biosciences IPO is Rs 100.
  • The shares of Anthem Biosciences IPO are subscribed 0.77 Times.

 

Anthem Biosciences IPO Valuation

The approximate valuation of Anthem Biosciences IPO based on its price band and RHP is:

Particulars Value
Upper Price Band Rs 570
Existing Shares (Qty) 56.16 Cr
Market Cap Rs 32,011.2 Cr
EPS (FY25) Rs 8.07
PE Ratio 70.63x
Industry PE 81.06x

 

Anthem Biosciences IPO Issue Size

Anthem Biosciences IPO issue size is Rs 3,395.00 Cr.

Issue Amount
Fresh Issue Rs 0 Cr
Offer For Sale Rs 3,395 Cr

 

Anthem Biosciences IPO Market Lot

An individual can apply for a minimum of 1 lot of 26 shares and a maximum of 13 lots (338 shares). Find the details below:

Application Lot Shares Amount
Retail Minimum 1 26 Rs 14,820
Retail Maximum 13 338 Rs 1,92,660

 

Anthem Biosciences IPO Share Offer

The shares of Anthem Biosciences IPO are subscribed 0.77 Times. The category-wise shares offered are as follows:

Category % Offered
Qualified Institutional Not more than 50%
Non-Institutional Not more than 15%
Retail Individual Not more than 35%

 

Anthem Biosciences IPO GMP (Grey Market Premium)

As on GMP (Tentative)
14 July 2025 Rs 100

Anthem Biosciences IPO GMP is purely for informational purposes. Invest in an IPO after thoroughly researching on your own.

Anthem Biosciences IPO Dates

Find below the dates for Anthem Biosciences IPO

Schedule Date
Basis of Allotment 17 July 2025
Refunds 18 July 2025
Credit to Demat Account 18 July 2025
IPO Listing Date 21 July 2025

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Net Sales 1103.24 1231.26 1056.92 1417.54 1840.65
Total Expenditure 695.5 665.8 633.88 912.53 1151.44
Operating Profit 407.74 565.45 423.04 505.01 689.21
Other Income 37.21 48.98 85.35 70.52 109.44
Interest 16.97 10.09 8.71 9.26 9.29
Depreciation 62.4 57.76 63.7 81.49 77.94
Exceptional Items 0 0 61.8 0 0
Profit Before Tax 365.58 546.59 497.78 484.77 711.42
Provision for Tax 94.27 140.6 112.11 109.99 205.24
Net Profit 271.31 405.99 385.67 374.78 506.19
Adjusted EPS (Rs.) 0.49 0.71 0.68 0.67 0.91

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Equity and Liabilities
Share Capital 8.48 8.78 114.1 111.82 111.82
Total Reserves 692.99 1346.69 1627.52 1821.26 2361.4
Borrowings 19.72 5.9 85.06 65.72 47.03
Other N/C liabilities 13.79 18.83 -11.18 -18.24 5.81
Current liabilities 284.88 223.05 267.61 422.26 450.18
Total Liabilities 1019.87 1603.24 2083.11 2402.82 2976.23
Assets
Net Block 361.41 329.01 448.89 477.71 624.06
Capital WIP 18.59 152.68 143.41 155.91 57.94
Intangible WIP 0 0 0 0 0
Investments 0 0 6.31 12.7 117.08
Loans & Advances 23.95 23.76 49.29 190.52 351.58
Other N/C Assets 0.12 0.72 0.58 0.49 2.5
Current Assets 615.81 1097.08 1434.63 1565.49 1823.07
Total Assets 1019.87 1603.24 2083.11 2402.82 2976.23
* Other Non-current Liabilities include Net deferred Liabilities

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Profit from operations 365.58 546.59 497.78 484.77 711.42
Adjustment 77.39 47.85 26.91 37.17 36.05
Changes in Assets & Liabilities -94.43 -138.1 -90.71 -237.54 -148.64
Tax Paid -71 -123 -115 -120 -159
Operating Cash Flow 277.55 333.35 318.98 164.41 439.84
Investing Cash Flow -196.09 -205.78 -377.91 -191.76 -246.31
Financing Cash Flow -63.27 180.68 52.85 -131.59 -66.42
Net Cash Flow 18.19 308.24 -6.07 -158.95 127.1
X